3rd Circ. Rejects Rehearing Bid From Niaspan Buyers
By Matthew Perlman · June 5, 2023, 8:54 PM EDT
The Third Circuit on Monday refused a rehearing bid from Niaspan buyers accusing AbbVie Inc. and Teva Pharmaceuticals Ltd. of scheming to delay a generic version of the cholesterol drug, after an...
To view the full article, register now.